Ordinary Index Rebalancing in the Solactive Global Genomics Immunology and Medical Revolution Index | May 2022

In the ordinary rebalance the following composition will be implemented effective open 01.06.2022:

10X GENOMICS INC
ABBVIE INC
AGILENT TECHNOLOGIES INC
ALLOGENE THERAPEUTICS INC
ALNYLAM PHARMACEUTICALS INC
ASTRAZENECA PLC
BEAM THERAPEUTICS INC
BEIGENE LTD-ADR
BIO-TECHNE CORP
BIOGEN INC
BIONTECH SE
BRISTOL-MYERS SQUIBB CO
CRISPR THERAPEUTICS AG
DANAHER CORP
EDITAS MEDICINE INC
ELI LILLY & CO
EXACT SCIENCES CORP
FATE THERAPEUTICS INC
GENMAB A/S
GENSCRIPT BIOTECH CORP
GILEAD SCIENCES INC
GUARDANT HEALTH INC
I-MAB
ILLUMINA INC
INNOVENT BIOLOGICS INC
INTELLIA THERAPEUTICS INC
INVITAE CORP
JAZZ PHARMACEUTICALS PLC
JOHNSON & JOHNSON
LONZA GROUP AG
MODERNA INC
NOVARTIS AG
NOVAVAX INC
PACIFIC BIOSCIENCES OF CALIFORNIA INC
PERKINELMER INC
PFIZER INC
QIAGEN NV
REGENERON PHARMACEUTICALS
ROCHE HOLDING AG
SAMSUNG BIOLOGICS CO LTD
SANOFI SA
SAREPTA THERAPEUTICS INC
SEAGEN INC
SORRENTO THERAPEUTICS INC
TG THERAPEUTICS INC
THERMO FISHER SCIENTIFIC INC
TWIST BIOSCIENCE CORP
ULTRAGENYX PHARMACEUTICAL INC
VERACYTE INC
VERTEX PHARMACEUTICALS INC